YASESMSGIPSR* – SIL Infliximab signature peptide qualifier
YASESMSGIPSR Stable Isotope Labeled Infliximab (IFX) peptide serves as a secondary internal standard to confirm IFX’s presence in biological samples by mass spectrometry.
SB-PEPTIDE’s Infliximab SIL signature peptide qualifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay. It is used in comnbination with Infliximab SIL peptide quantifier, that is used as primary internal standard for IFX detection and quantification.
Technical specification
 |
Sequence : YASESMSGIPS-R*- [R*= R(13C/15N)] |
 |
MW : 1 294.33 Da (C53H85N15O20S) |
 |
Purity : > 95% |
 |
Counter-Ion : TFA Salts (see option TFA removal) |
 |
Delivery format : Freeze dried in propylene 2mL microtubes |
 |
Other name : SIL IFX signature peptide qualifier |
 |
Peptide Solubility Guideline |
 |
Bulk peptide quantities available |
Price
| Catalog code | Size | Price € | Price $ USD |
| SB289-0.1MG | 0.1 mg | 385 | 481 |